A handful of TNF-specific monoclonal antibodies are currently approved for treating rheumatoid arthritis and other diseases such as juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, ulcerative colitis, Crohn’s disease, and psoriasis [236]. The gene discussed is TNF; the disease is rheumatoid arthritis.